🎉 M&A multiples are live!
Check it out!

Schott Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Schott Pharma and other public comps.

See Schott Pharma Valuation Multiples

Schott Pharma Overview

About Schott Pharma

Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.


Founded

1884

HQ

Germany
Employees

4.7K+

Financials

LTM Revenue $1.0B

LTM EBITDA $275M

EV

$3.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Schott Pharma Financials

Schott Pharma has a last 12-month revenue of $1.0B and a last 12-month EBITDA of $275M.

In the most recent fiscal year, Schott Pharma achieved revenue of $998M and an EBITDA of $274M.

Schott Pharma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Schott Pharma valuation multiples based on analyst estimates

Schott Pharma P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $856M $937M $998M $1.0B XXX
Gross Profit $309M $330M $336M XXX XXX
Gross Margin 36% 35% 34% XXX XXX
EBITDA $226M $255M $274M $275M XXX
EBITDA Margin 26% 27% 27% 27% XXX
Net Profit $131M $158M $156M XXX XXX
Net Margin 15% 17% 16% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Schott Pharma Stock Performance

As of February 7, 2025, Schott Pharma's stock price is EUR 24 (or $25).

Schott Pharma has current market cap of EUR 3.6B (or $3.8B), and EV of EUR 3.7B (or $3.8B).

See Schott Pharma trading valuation data

Schott Pharma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$3.8B $3.8B XXX XXX XXX XXX $1.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Schott Pharma Valuation Multiples

As of February 7, 2025, Schott Pharma has market cap of $3.8B and EV of $3.8B.

Schott Pharma's trades at 3.7x LTM EV/Revenue multiple, and 13.9x LTM EBITDA.

Analysts estimate Schott Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Schott Pharma and 10K+ public comps

Schott Pharma Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $3.8B XXX XXX XXX
EV/Revenue 3.8x XXX XXX XXX
EV/EBITDA 13.8x XXX XXX XXX
P/E 23.8x XXX XXX XXX
P/E/Growth 1.6x XXX XXX XXX
EV/FCF 54.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Schott Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Schott Pharma Valuation Multiples

Schott Pharma's NTM/LTM revenue growth is 9%

Schott Pharma's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $29K for the same period.

Over next 12 months, Schott Pharma's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Schott Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Schott Pharma and other 10K+ public comps

Schott Pharma Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 7% XXX XXX XXX XXX
EBITDA Margin 27% XXX XXX XXX XXX
EBITDA Growth 7% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 37% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $29K XXX XXX XXX XXX
S&M Expenses to Revenue 8% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue 3% XXX XXX XXX XXX
Opex to Revenue 14% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Schott Pharma Public Comps

See valuation multiples for Schott Pharma public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Ansell XXX XXX XXX XXX XXX XXX
Poly Medicure XXX XXX XXX XXX XXX XXX
Fresenius Medical Care XXX XXX XXX XXX XXX XXX
Fresenius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Schott Pharma M&A and Investment Activity

Schott Pharma acquired  XXX companies to date.

Last acquisition by Schott Pharma was  XXXXXXXX, XXXXX XXXXX XXXXXX . Schott Pharma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Schott Pharma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Schott Pharma

When was Schott Pharma founded? Schott Pharma was founded in 1884.
Where is Schott Pharma headquartered? Schott Pharma is headquartered in Germany.
How many employees does Schott Pharma have? As of today, Schott Pharma has 4.7K+ employees.
Is Schott Pharma publicy listed? Yes, Schott Pharma is a public company listed on ETR.
What is the stock symbol of Schott Pharma? Schott Pharma trades under 1SXP ticker.
When did Schott Pharma go public? Schott Pharma went public in 2023.
Who are competitors of Schott Pharma? Similar companies to Schott Pharma include e.g. Ansell, Poly Medicure, Fresenius Medical Care, Fresenius.
What is the current market cap of Schott Pharma? Schott Pharma's current market cap is $3.8B
What is the current revenue of Schott Pharma? Schott Pharma's last 12-month revenue is $1.0B.
What is the current EBITDA of Schott Pharma? Schott Pharma's last 12-month EBITDA is $275M.
What is the current EV/Revenue multiple of Schott Pharma? Current revenue multiple of Schott Pharma is 3.7x.
What is the current EV/EBITDA multiple of Schott Pharma? Current EBITDA multiple of Schott Pharma is 13.9x.
What is the current revenue growth of Schott Pharma? Schott Pharma revenue growth between 2023 and 2024 was 7%.
Is Schott Pharma profitable? Yes, Schott Pharma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.